Cheng-Chung Wu

Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage

Chun‐Jen Liu, Po‐Huang Lee, Deng‐Yn Lin et al. · Journal of Hepatology · 2009 · 153 citations

Medicine, Oncology, Pharmacology +9

Long-Term Results of a Randomized, Observation-Controlled, Phase III Trial of Adjuvant Interferon Alfa-2b in Hepatocellular Carcinoma After Curative Resection

Li‐Tzong Chen, Miin-Fu Chen, Lung-An Li et al. · Annals of Surgery · 2011 · 129 citations

Pharmacy, Oncology, Pharmacotherapy +17

Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer

Yutaka Yonemura, Cheng-Chung Wu, Norimasa Fukushima et al. · International Journal of Clinical Oncology · 2008 · 96 citations · Full text

Medicine, Oncology, Surgery +11

Somatic mutations of mitochondrial genome in hepatocellular carcinoma

Pen-Hui Yin, Cheng-Chung Wu, Jin‐Ching Lin et al. · Mitochondrion · 2009 · 94 citations

Medicine, Genetics, Molecular Genetics +16

Combined Primary Neuroendocrine Carcinoma and Hepatocellular Carcinoma of the Liver

Chii-Shuenn Yang, Mei‐Chin Wen, Yee‐Jee Jan et al. · Journal of the Chinese Medical Association · 2009 · 53 citations

Medicine, Oncology, Pathology +17